Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Noll

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 4, 2009
Dual blockade versus single blockade of the renin-angiotensin system in the light of ONTARGETIsabella Sudano, Georg Noll
Current Pharmaceutical Design|August 25, 2011
Vascular abnormalities in essential hypertensionIsabella Sudano, Susanne Roas, Georg Noll
European Heart Journal|October 6, 2018
Pulsatile temporal vein caused by severe tricuspid regurgitationVictor Duerst, Georg Noll, Patric Biaggi
Seminars in Hematology|May 28, 2014
Direct oral anticoagulants in atrial fibrillationGeorg Noll, Sarah Noll, David Hürlimann
Swiss Medical Weekly|July 26, 2008
Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemiaWalter F Riesen, Georg Noll, Roger Dariolo, et al.
Current Medical Research and Opinion|March 10, 2004
Lipid-lowering therapy: strategies for improving complianceWalter F Riesen, Roger Darioli, Georg Noll
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 5, 2013
Potential new indications and future studiesIsabella Sudano, Georg Noll, Thomas F Luscher
Swiss Medical Weekly|May 17, 2011
Persistent dyslipidemia in statin-treated patients: the focus on comprehensive lipid management survey in Swiss patientsIsabella Sudano, Lorenzo Hess, Georg Noll, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|February 20, 2010
Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in SwitzerlandAndres Jaussi, Georg Noll, Bernhard Meier, et al.
Journal of Cardiovascular Pharmacology|September 10, 2003
ETA receptors mediate vasoconstriction of large conduit arteries during reduced flow in humansLukas E Spieker, Thomas F Lüscher, Georg Noll
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 4, 2009
Dual blockade versus single blockade of the renin-angiotensin system in the light of ONTARGETIsabella Sudano, Georg Noll
Current Pharmaceutical Design|August 25, 2011
Vascular abnormalities in essential hypertensionIsabella Sudano, Susanne Roas, Georg Noll
European Heart Journal|October 6, 2018
Pulsatile temporal vein caused by severe tricuspid regurgitationVictor Duerst, Georg Noll, Patric Biaggi
Seminars in Hematology|May 28, 2014
Direct oral anticoagulants in atrial fibrillationGeorg Noll, Sarah Noll, David Hürlimann
Swiss Medical Weekly|July 26, 2008
Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemiaWalter F Riesen, Georg Noll, Roger Dariolo, et al.
Current Medical Research and Opinion|March 10, 2004
Lipid-lowering therapy: strategies for improving complianceWalter F Riesen, Roger Darioli, Georg Noll
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 5, 2013
Potential new indications and future studiesIsabella Sudano, Georg Noll, Thomas F Luscher
Swiss Medical Weekly|May 17, 2011
Persistent dyslipidemia in statin-treated patients: the focus on comprehensive lipid management survey in Swiss patientsIsabella Sudano, Lorenzo Hess, Georg Noll, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|February 20, 2010
Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in SwitzerlandAndres Jaussi, Georg Noll, Bernhard Meier, et al.
Journal of Cardiovascular Pharmacology|September 10, 2003
ETA receptors mediate vasoconstriction of large conduit arteries during reduced flow in humansLukas E Spieker, Thomas F Lüscher, Georg Noll
Pageof 10